Trial Profile
Randomized, double-blind, placebo-controlled, single-dose, multiple-dose trial for Futagliptin benzoic acid in T2DM to evaluate tolerance, pharmacokinetics and pharmacodynamics
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Fotagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 17 Sep 2018 New trial record